Pharmaceuticals

Unlocking Solutions to Chronic Disease: Q&A with Bobby Azamian

bexib
By bexib 0 Min Read

The CEO of Tarsus Pharmaceuticals explains how the company is finding solutions that may have been overlooked before.

You Might Also Like

APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology

Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins

New ways to determine drug value with health equity in mind

Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions

Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer

Share This Article
Previous Article 5 Content Marketing Ideas for July 2024
Next Article Balancing for a soft landing
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Editor’s Pick: Top 3 Features of 2024
Banking
New e-commerce tools: December 26, 2024
Retail & E-commerce
Is it a wise choice to join?
Insurance
Warwickshire’s biggest secret revealed as new speakeasy bar opens
Hospitality & Tourism